Encouraging news for people with primary or secondary progressive MS
Source F1000 Prime: Fox et al. present the results of the eagerly awaited SPRINT-MS trial – a multi-centre phase II double blinded placebo controlled study of ibudilast in decreasing brain atrophy in progressive forms of multiple sclerosis (MS).
Encouraging news for people with primary or secondary progressive MS Read More »









